Oligomerization interface of RAGE receptor revealed by MS-monitored hydrogen deuterium exchange.

ABSTRACT: Activation of the receptor for advanced glycation end products (RAGE) leads to a chronic proinflammatory signal, affecting patients with a variety of diseases. Potentially beneficial modification of RAGE activity requires understanding the signal transduction mechanism at the molecular level. The ligand binding domain is structurally uncoupled from the cytoplasmic domain, suggesting receptor oligomerization is a requirement for receptor activation. In this study, we used hydrogen-deuterium exchange and mass spectrometry to map structural differences between the monomeric and oligomeric forms of RAGE. Our results indicated the presence of a region shielded from exchange in the oligomeric form of RAGE and led to the identification of a new oligomerization interface localized at the linker re

SUBMITTER: Sitkiewicz E 

PROVIDER: S-EPMC3788119 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature